Pharmafile Logo

Apodi Ltd

Established in 2006 by a group of highly experienced outsourcing business specialists, Apodi provides comprehensive outsourcing solutions to pharmaceutical and healthcare businesses and organisations. We recognise that the business environment for these industry sectors is changing and that there is a need for highly professional, tailored outsourcing services offering a rapid, effective response and delivering the best ROI. Through commercial insight, market intelligence and highly motivated people, Apodi helps our clients achieve improved outcomes and performance. Over the years we have worked hard to break the traditional model with a focus on the changing NHS environment and the challenge we all face to improve patient outcomes.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Company Details

One St Peters Road, Maidenhead, Berks, SL6 7QU, United Kingdom
+44 (0)1628 500 890

 Latest Content from PMHub 

Rare Diseases – not as rare as you think

Julie Cox reflects on our passion working in the rare disease space - helping to bring vital education to healthcare professionals, to benefit patients

Patient Recruitment: Think Global, Act Local

Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

Together Caring for Rare Disease

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

Rare and Orphan Diseases

Why we need authentic and personalised communications in the evolving rare disease space. By Sarah Mikhailov, Managing Director, Brand at Havas Life Medicom

Origins’ Strategy Offering Explained

What do we mean when we say that at Origins, we provide patient focused strategies throughout the product lifecycle? In this short video Origins’ Director Su Smith explains our strategy...

Applying Vibrotactile Stimulation to Improve Parkinson’s

Videos and Podcasts | February 16, 2023 | Impetus Digital

Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

Impetus Digital’s Virtual Learning Programs named PM360’s Most Innovative Services of 2022

Press Releases | February 16, 2023 | Impetus Digital

About the AwardToronto, ON, December 15, 2022 — PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Impetus Digital’s Virtual...

End-to-end patient strategy: Making a treatment for patients, with patients

The integration of patient engagement in all stages of a product lifecycle is starting to become much more commonplace and you may start to hear the term end-to-end patient strategy...

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

Press Releases | February 13, 2023 | OPEN Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...